HIV Coinfection

The aim of this supplement is to enhance efforts around the National HIV AIDS Strategy with an emphasis on building collaborations with health departments, identifying community needs, prioritizing research directions, and conducting formative research relevant to the treatment cascade. These projects were especially focused on factors associated with linkage to HIV care, engagement, and retention in part to identify targets for intervention.

  • Term: 1 year (when available)
  • Number of awards: Dependent on available funding
  • Award amount: $100,000 direct costs

1 Awards

Award Recipient Award date Award Type
Mediators of Fatty Liver Disease Jennifer Price, MD Spring HIV Coinfection
Contacts

  • Mediators of Fatty Liver Disease

    Mediators of Fatty Liver Disease

    Abstract

    As the prevalence of metabolic syndrome and obesity rises, and as more effective HCV treatments become available, fatty liver disease will likely become a leading cause of liver disease in persons living with HIV. The purpose of this study is to determine the association of metabolic, host genetic, and viral factors with hepatic steatosis (Aim 1) and hepatic fibrosis (Aim 2) in HIV-infected adults with and without HCV-coinfection.

Subscribe to HIV Coinfection